author-photo

Jean-Pierre M. Ayoub

Université de Montréal

55

Papers

2209

Citations

Citation Trend

Filter By

Papers (35) Sort By

Journal Conference Others

Abstract PS11-03: Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: A subgroup analysis of germline BRCA1 or BRCA2 mutations from the phase 3 BROCADE3 trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD4-01: First-line veliparib plus carboplatin/paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Planned subgroup analysis from the phase 3 BROCADE3 trial

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial.

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (58)
Veliparib (V) monotherapy (monoTx) following combination therapy with V + carboplatin/paclitaxel (CP) in patients with gBRCA-associated advanced breast cancer: Exploratory results from BROCADE3.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Veliparib (V) monotherapy after progression on placebo (PL) + carboplatin/paclitaxel (CP) in patients with advanced HER2-negative gBRCA-associated breast cancer: Crossover outcomes and exploratory biomarker analyses in BROCADE3.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Arterial thrombosis and coronavirus disease 2019 in a patient with cancer.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Neoadjuvant Therapy (NAT) in Pancreatic Adenocarcinoma (PAC): A Single Center Experience

2019
Show All
- Source
- Cite
- Save
Citations (0)
Role of neoadjuvant therapy (NAT) in pancreatic adenocarcinoma (PAC): A single center experience.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Implementing DPYD*2A genotyping in clinical practice, the Quebec experience.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

2018 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (17)